Search results
What Factors Will Drive Pfizer's Q1 Performance?
Forbes· 5 days agoWe expect the company to post revenue of $13.8 billion and earnings of $0.50 on a per share and adjusted basis.
PFE Shares Experience Decline in Value – Knox Daily
Knox Daily· 6 days agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Pfizer Inc. shares valued at $79,401 were purchased by Gottlieb Scott ...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
WSAU Wausau· 6 days agoBy Blake Brittain (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on...
These 3 High-Yield Stocks Have Been Growing Their Dividends Non-Stop, And Analysts Expect Their...
Benzinga via Yahoo Finance· 1 day agoIncome-seeking investors are always on the lookout for reliable high-yield stocks with a history of...
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy
Investor's Business Daily· 4 days agoPfizer won FDA approval for a new hemophilia B gene therapy, a rival to Hemgenix from CSL and Uniqure.
Labcorp nets companion diagnostic approval for Pfizer’s hemophilia B gene therapy Beqvez
FierceBiotech· 2 days agoThe FDA has bestowed a green light to a companion diagnostic forPfizer’s recently approved...
Why Pfizer (PFE) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 2 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
What's Going On With Pfizer Stock On Thursday? - GSK (NYSE:GSK), Pfizer (NYSE:PFE)
Benzinga· 6 days agoGSK Plc GSK has reportedly taken legal action against Pfizer Inc PFE and BioNTech SE BNTX in a...
US FDA approves Pfizer's gene therapy for rare bleeding disorder
Reuters· 4 days ago, opens new tab gene therapy for hemophilia B on Friday, the second such therapy for the rare...
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia - Pfizer (NYSE:PFE)
Benzinga· 5 days agoFriday, the FDA approved Pfizer Inc’s PFE Beqvez (fidanacogene elaparvovec-dzkt) for moderate to...